The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Interferon-Lambda: A New Addition to an Old Family
Open accessAbstract
The discovery and initial description of the interferon-lambda (IFN-lambda) family in early 2003 opened an exciting new chapter in the field of IFN research. There are 3 IFN-lambda genes that encode 3 distinct but highly related proteins denoted IFN-lambda1, -lambda2, and -lambda3. These proteins are also known as interleukin-29 (IL-29), IL-28A, and IL-28B, respectively. Collectively, these 3 cytokines comprise the type III subset of IFNs. They are distinct from both type I and type II IFNs for a number of reasons, including the fact that they signal through a heterodimeric receptor complex that is different from the receptors used by type I or type II IFNs. Although type I IFNs (IFN-alpha/beta) and type III IFNs (IFN-lambda) signal via distinct receptor complexes, they activate the same intracellular signaling pathway and many of the same biological activities, including antiviral activity, in a wide variety of target cells. Consistent with their antiviral activity, expression of the IFN-lambda genes and their corresponding proteins is inducible by infection with many types of viruses. Therefore, expression of the type III IFNs (IFN-lambdas) and their primary biological activity are very similar to the type I IFNs. However, unlike IFN-alpha receptors which are broadly expressed on most cell types, including leukocytes, IFN-lambda receptors are largely restricted to cells of epithelial origin. The potential clinical importance of IFN-lambda as a novel antiviral therapeutic agent is already apparent. In addition, preclinical studies by several groups indicate that IFN-lambda may also be useful as a potential therapeutic agent for other clinical indications, including certain types of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
CELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890
Antiviral Actions of Interferons
Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
AP-1: a double-edged sword in tumorigenesis
Eferl, R., & Wagner, E. F. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1209 · Cited by 2,242
Immune Signaling by RIG-I-like Receptors
Loo, Y.-M., & Gale, M. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.003 · Cited by 1,875
IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex
Kotenko, S. V., Gallagher, G., Baurin, V. V., Lewis-Antes, A., Shen, M., Shah, N. K., Langer, J. A., Sheikh, F., Dickensheets, H., & Donnelly, R. P. (2003) · Nature Immunology · doi:10.1038/ni875 · Cited by 1,868
Self-citationInterferons, interferon‐like cytokines, and their receptors
Pestka, S., Krause, C. D., & Walter, M. R. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00204.x · Cited by 1,766
Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-γ Genes
Dalton, D. K., Pitts-Meek, S., Keshav, S., Figari, I. S., Bradley, A., & Stewart, T. A. (1993) · Science · doi:10.1126/science.8456300 · Cited by 1,727
IL-28, IL-29 and their class II cytokine receptor IL-28R
Sheppard, P., Kindsvogel, W., Xu, W., Henderson, K., Schlutsmeyer, S., Whitmore, T. E., Kuestner, R., Garrigues, U., Birks, C., Roraback, J., et al. (2003) · Nature Immunology · doi:10.1038/ni873 · Cited by 1,570
Immune Response in Mice that Lack the Interferon-γ Receptor
Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilček, J., Zinkernagel, R. M., & Aguet, M. (1993) · Science · doi:10.1126/science.8456301 · Cited by 1,548
I nterleukin -10 and R elated C ytokines and R eceptors
Pestka, S., Krause, C. D., Sarkar, D., Walter, M. R., Shi, Y., & Fisher, P. B. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104622 · Cited by 1,094
THE IFNγ RECEPTOR:A Paradigm for Cytokine Receptor Signaling
Bach, E. A., Aguet, M., & Schreiber, R. D. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.563 · Cited by 1,034
NF-κB signaling pathways in mammalian and insect innate immunity
Silverman, N., & Maniatis, T. (2001) · Genes & Development · doi:10.1101/gad.909001 · Cited by 907
Sommereyns, C., Paul, S., Staeheli, P., & Michiels, T. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000017 · Cited by 772
Wathelet, M. G., Lin, C. H., Parekh, B. S., Ronco, L. V., Howley, P. M., & Maniatis, T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80051-9 · Cited by 730
Interferons α and β as Immune Regulators—A New Look
Biron, C. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00154-6 · Cited by 667
Ank, N., West, H., Bartholdy, C., Eriksson, K., Thomsen, A. R., & Paludan, S. R. (2006) · Journal of Virology · doi:10.1128/jvi.80.9.4501-4509.2006 · Cited by 596
Links between innate and adaptive immunity via type I interferon
Le Bon, A., & Tough, D. F. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00354-0 · Cited by 582
Marcello, T., Grakoui, A., Barba–Spaeth, G., Machlin, E. S., Kotenko, S. V., Macdonald, M. R., & Rice, C. M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.052 · Cited by 561
Self-citationXie, M.-H., Aggarwal, S., Ho, W.-H., Foster, J., Zhang, Z., Stinson, J., Wood, W. I., Goddard, A. D., & Gurney, A. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005304200 · Cited by 540
Gautier, G., Humbert, M., Deauvieau, F., Scuiller, M., Hiscott, J., Bates, E. E. M., Trinchieri, G., Caux, C., & Garrone, P. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041964 · Cited by 537
Coccia, E. M., Severa, M., Giacomini, E., Monneron, D., Remoli, M. E., Julkunen, I., Cella, M., Lande, R., & Uzé, G. (2004) · European Journal of Immunology · doi:10.1002/eji.200324610 · Cited by 490
Collins, P. L., & Melero, J. A. (2011) · Virus Research · doi:10.1016/j.virusres.2011.09.020 · Cited by 455
Spann, K. M., Tran, K.-C., Chi, B., Rabin, R. L., & Collins, P. L. (2004) · Journal of Virology · doi:10.1128/jvi.78.8.4363-4369.2004 · Cited by 447
Lambda Interferon Inhibits Hepatitis B and C Virus Replication
Robek, M. D., Boyd, B. S., & Chisari, F. V. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3851-3854.2005 · Cited by 431
The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion
Levy, D. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00027-7 · Cited by 428 · cited 1×
“Type I IFNs (IFN-a/b/ o/e/k in humans) possess strong intrinsic antiviral activity, and are able to induce a potent antiviral state in a wide variety of cells (Levy and Garcia-Sastre 2001; Samuel 2001).”
BackgroundClinical features of dominant and recessive interferon γ receptor 1 deficiencies
Dorman, S. E., Picard, C., Lammas, D., Heyne, K., van Dissel, J. T., Baretto, R., Rosenzweig, S. D., Newport, M., Levin, M., Roesler, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17552-1 · Cited by 422
Identification of the Functional Interleukin-22 (IL-22) Receptor Complex
Kotenko, S. V., Izotova, L. S., Mirochnitchenko, O. V., Esterova, E., Dickensheets, H., Donnelly, R. P., & Pestka, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007837200 · Cited by 400
Self-citationKotenko, S. V., Krause, C. D., Izotova, L. S., Pollack, B. P., Wu, W., & Pestka, S. (1997) · The EMBO Journal · doi:10.1093/emboj/16.19.5894 · Cited by 381
Self-citationHwang, S. Y., Hertzog, P. J., Holland, K. A., Sumarsono, S. H., Tymms, M. J., Hamilton, J. A., Whitty, G., Bertoncello, I., & Kola, I. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11284 · Cited by 377
Viral Infections Activate Types I and III Interferon Genes through a Common Mechanism
Onoguchi, K., Yoneyama, M., Takemura, A., Akira, S., Taniguchi, T., Namiki, H., & Fujita, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608618200 · Cited by 355
Doyle, S. E., Schreckhise, H., Khuu‐Duong, K., Henderson, K., Rosler, R., Storey, H., Yao, L., Liu, H., Barahmand‐pour, F., Sivakumar, P., et al. (2006) · Hepatology · doi:10.1002/hep.21312 · Cited by 348
Interferon-alpha in tumor immunity and immunotherapy
Belardelli, F., Ferrantini, M., Proietti, E., & Kirkwood, J. M. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00022-3 · Cited by 337
Induction and function of type I and III interferon in response to viral infection
Levy, D. E., Marié, I. J., & Durbin, J. E. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.11.001 · Cited by 314
Österlund, P. I., Pietilä, T. E., Veckman, V., Kotenko, S. V., & Julkunen, I. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3434 · Cited by 301
Self-citationDumoutier, L., Tounsi, A., Michiels, T., Sommereyns, C., Kotenko, S. V., & Renauld, J.-C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404789200 · Cited by 291
Self-citationThe expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain
Donnelly, R. P., Sheikh, F., Kotenko, S. V., & Dickensheets, H. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0204117 · Cited by 289
Self-citationInterferon-κ, a Novel Type I Interferon Expressed in Human Keratinocytes
LaFleur, D. W., Nardelli, B., Tsareva, T., Mather, D., Feng, P., Semenuk, M., Taylor, K., Buergin, M., Chinchilla, D., Roshke, V., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102502200 · Cited by 288
Class II cytokine receptors and their ligands: Key antiviral and inflammatory modulators
Renauld, J.-C. (2003) · Nature Reviews Immunology · doi:10.1038/nri1153 · Cited by 265
Lasfar, A., Lewis-Antes, A., Smirnov, S. V., Anantha, S., Abushahba, W., Tian, B., Reuhl, K., Dickensheets, H., Sheikh, F., Donnelly, R. P., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3653 · Cited by 254
Self-citationMuir, A. J., Shiffman, M. L., Zaman, A., Yoffe, B., de la Torre, A., Flamm, S., Gordon, S. C., Marotta, P., Vierling, J. M., Carlos Lopez-Talavera, J., et al. (2010) · Hepatology · doi:10.1002/hep.23743 · Cited by 249
IFN-α Regulates TLR-Dependent Gene Expression of IFN-α, IFN-β, IL-28, and IL-29
Sirén, J., Pirhonen, J., Julkunen, I., & Matikainen, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.1932 · Cited by 238
Characterization of the type I interferon locus and identification of novel genes☆
Hardy, M. P., Owczarek, C. M., Jermiin, L. S., Ejdebäck, M., & Hertzog, P. J. (2004) · Genomics · doi:10.1016/j.ygeno.2004.03.003 · Cited by 238
Biological activity of interleukins-28 and -29: Comparison with type I interferons
MEAGER, A., VISVALINGAM, K., DILGER, P., BRYAN, D., & WADHWA, M. (2005) · Cytokine · doi:10.1016/j.cyto.2005.04.003 · Cited by 220
The family of IL-10-related cytokines and their receptors: related, but to what extent?
Kotenko, S. V. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00012-6 · Cited by 213
Self-citationBrand, S., Beigel, F., Olszak, T., Zitzmann, K., Eichhorst, S. T., Otte, J.-M., Diebold, J., Diepolder, H., Adler, B., Auernhammer, C. J., et al. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00126.2005 · Cited by 205
Witte, K., Gruetz, G., Volk, H.-D., Looman, A. C., Asadullah, K., Sterry, W., Sabat, R., & Wolk, K. (2009) · Genes & Immunity · doi:10.1038/gene.2009.72 · Cited by 198
Antitumor Activity of IFN-λ in Murine Tumor Models
Sato, A., Ohtsuki, M., Hata, M., Kobayashi, E., & Murakami, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7686 · Cited by 195
A Bacterial Protein Targets the BAHD1 Chromatin Complex to Stimulate Type III Interferon Response
Lebreton, A., Lakisic, G., Job, V., Fritsch, L., Tham, T. N., Camejo, A., Matteï, P.-J., Regnault, B., Nahori, M.-A., Cabanes, D., et al. (2011) · Science · doi:10.1126/science.1200120 · Cited by 193
The Class II cytokine receptor (CRF2) family: overview and patterns of receptor–ligand interactions
Langer, J. A., Cutrone, E. C., & Kotenko, S. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.10.001 · Cited by 193
Self-citationTissari, J., Sirén, J., Meri, S., Julkunen, I., & Matikainen, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.4289 · Cited by 190
Österlund, P., Veckman, V., Sirén, J., Klucher, K. M., Hiscott, J., Matikainen, S., & Julkunen, I. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9608-9617.2005 · Cited by 183
Sheikh, F., Baurin, V. V., Lewis-Antes, A., Shah, N. K., Smirnov, S. V., Anantha, S., Dickensheets, H., Dumoutier, L., Renauld, J.-C., Zdanov, A., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2006 · Cited by 173
Self-citationThe interferon gamma (IFN-γ) receptor: a paradigm for the multichain cytokine receptor
Pestka, S., Kotenko, S. V., Muthukumaran, G., Izotova, L. S., Cook, J. R., & Garotta, G. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00009-9 · Cited by 170
Self-citationMaher, S. G., Sheikh, F., Scarzello, A. J., Romero-Weaver, A. L., Baker, D. P., Donnelly, R. P., & Gamero, A. M. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.7.6192 · Cited by 159
Self-citationHör, S., Pirzer, H., Dumoutier, L., Bauer, F., Wittmann, S., Sticht, H., Renauld, J., Malefyt, R. D. W., & Fickenscher, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405000200 · Cited by 144
Maeyer, E. D., & Maeyer‐Guignard, J. D. (1998) · International Reviews of Immunology · doi:10.3109/08830189809084487 · Cited by 144
Targeted disruption of the interferon-γ receptor 2 gene results in severe immune defects in mice
Lu, B., Ebensperger, C., Dembić, Z., Wang, Y., Kvatyuk, M., Lu, T., Coffman, R. L., Pestka, S., & Rothman, P. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8233 · Cited by 141
IL-28 Elicits Antitumor Responses against Murine Fibrosarcoma
Numasaki, M., Tagawa, M., Iwata, F., Suzuki, T., Nakamura, A., Okada, M., Iwakura, Y., Aiba, S., & Yamaya, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5086 · Cited by 133
DUMOUTIER, L., LEJEUNE, D., HOR, S., FICKENSCHER, H., & RENAULD, J.-C. (2003) · Biochemical Journal · doi:10.1042/bj20021935 · Cited by 128
The role of transposable elements in the regulation of IFN-λ1 gene expression
Thomson, S. J. P., Goh, F. G., Banks, H., Krausgruber, T., Kotenko, S. V., Foxwell, B. M. J., & Udalova, I. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904477106 · Cited by 127
Self-citationSteinhoff, U., Müller, U., Schertler, A., Hengartner, H., Aguet, M., & Zinkernagel, R. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2153-2158.1995 · Cited by 126
Antitumor activity of Type I and Type III interferons in BNL hepatoma model
Abushahba, W., Balan, M., Castaneda, I., Yuan, Y., Reuhl, K. R., Raveche, E. S., de la Torre, A., Lasfar, A., & Kotenko, S. V. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0831-3 · Cited by 122
Self-citationThe role of IL-12, IL-23 and IFN-γ in immunity to viruses
Novelli, F., & Casanova, J. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.03.009 · Cited by 117
Bartlett, N., Buttigieg, K., Kotenko, S., & Smith, G. L. (2005) · Journal of General Virology · doi:10.1099/vir.0.80904-0 · Cited by 117
Self-citationMechanisms of Type III Interferon Expression
Iversen, M. B., & Paludan, S. R. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0063 · Cited by 112
Full house: 12 receptors for 27 cytokines
Kotenko, S. V., & Langer, J. A. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.01.003 · Cited by 109
Self-citationRegulation of apoptosis by type III interferons
Li, W., Lewis-Antes, A., Huang, J., Balan, M., & Kotenko, S. V. (2008) · Cell Proliferation · doi:10.1111/j.1365-2184.2008.00558.x · Cited by 106
Self-citationInterferon Lambda: A New Sword in Cancer Immunotherapy
Lasfar, A., Abushahba, W., Balan, M., & Cohen-Solal, K. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/349575 · Cited by 102
Brand, S., Zitzmann, K., Dambacher, J., Beigel, F., Olszak, T., Vlotides, G., Eichhorst, S. T., Göke, B., Diepolder, H. M., & Auernhammer, C. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.04.004 · Cited by 91
Induction and function of virus-specific CD4+ T cell responses
Whitmire, J. K. (2011) · Virology · doi:10.1016/j.virol.2010.12.015 · Cited by 90
Interferon-lambda and therapy for chronic hepatitis C virus infection
Donnelly, R. P., Dickensheets, H. L., & OʼBrien, T. R. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.07.002 · Cited by 76
Self-citationMolecular Cloning, Expression, and Characterization of Chicken IFN -λ
Karpala, A. J., Morris, K. R., Broadway, M. M., McWaters, P. G. D., O’Neil, T. E., Goossens, K. E., Lowenthal, J. W., & Bean, A. G. D. (2008) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2007.0117 · Cited by 70
Interferon-Lambda as a Potential Therapeutic Agent in Cancer Treatment
Steen, H. C., & Gamero, A. M. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0058 · Cited by 57
Preclinical and Clinical Development of Pegylated Interferon-Lambda 1 in Chronic Hepatitis C
Ramos, E. L. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0066 · Cited by 57
Interleukin-28 and Interleukin-29: Novel Regulators of Skin Biology
Wolk, K., Witte, K., & Sabat, R. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0064 · Cited by 38
What Have We Learned from the IL28 Receptor Knockout Mouse?
Mordstein, M., Michiels, T., & Staeheli, P. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0061 · Cited by 33
Generation of mice with a conditional Stat1 null allele
Wallner, B., Leitner, N. R., Vielnascher, R. M., Kernbauer, E., Kolbe, T., Karaghiosoff, M., Rülicke, T., Decker, T., & Müller, M. M. (2011) · Transgenic Research · doi:10.1007/s11248-011-9519-5 · Cited by 31
Frasca, L., & Lande, R. (2011) · The Scientific World JOURNAL · doi:10.1100/2011/873895 · Cited by 9
Hasegawa, S., Mori, N., Satomi, M., Jiang, D., Hotta, H., Matsushige, T., & Ichiyama, T. (2011) · Cytokine · doi:10.1016/j.cyto.2011.09.003 · Cited by 6
Interferon-Free Regimens: The Near Future, the Likely and the Not So Likely
Shiffman, M. L. (2011) · Clinics in Liver Disease · doi:10.1016/j.cld.2011.05.004 · Cited by 6
Cited by
Immune Signaling by RIG-I-like Receptors
Loo, Y.-M., & Gale, M. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.003 · Cited by 1,875
“…virus infection and signaling through the RLRs also induces the expression of the IFN-l family of IL-10-related cytokines known collectively as type III interferon (IFN-l) (as reviewed in Donnelly and Kotenko, 2010) and various proinflammatory cytokines to control infection (Poeck et al., 2010).”
BackgroundAntitumour actions of interferons: implications for cancer therapy
Parker, B. S., Rautela, J., & Hertzog, P. J. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.14 · Cited by 907
The immunogenetics of Psoriasis: A comprehensive review
Harden, J. L., Krueger, J. G., & Bowcock, A. M. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.07.008 · Cited by 616
Zhu, L.-Y., Nie, L., Zhu, G., Xiang, L.-X., & Shao, J.-Z. (2013) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2012.04.001 · Cited by 548
Decoding type I and III interferon signalling during viral infection
Mesev, E. V., LeDesma, R. A., & Ploss, A. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0421-x · Cited by 538
Metadata
- Authors
- Donnelly, R. P., & Kotenko, S. V.
- Venue
- Journal of Interferon & Cytokine Research
- Publisher
- SAGE Publications
- Published
- 2010-08
- Volume
- 30
- Issue
- 8
- Pages
- 555-564
- ISSN
- 1079-9907 (ISSN-L)
- 1557-7465
- OpenAlex
- W1973309978
- Cited by
- 420
- References
- 82
- FWCI
- 11.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.